Abstract
Gram-negative bacteria such as Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp., Salmonella and Helicobacter pylori are multiresistant bacteria of clinical interest. Recombinant phage endolysins therefore appear as potential new antimicrobials to combat infections caused by antibiotic-resistant Gram-negative bacteria. Endolysins target the peptidog…